Clinical Trials

Toll-Free: 866.320.4573

Call Us Toll Free:

866.223.2273 x1234

Clinical Trial in Females for Female Pattern Hair Loss

Study:

A Phase 3 Multi-Center Parallel Design Clinical Trial to Compare the Efficacy and Safety of 5% Minoxidil Foam vs. Vehicle in Females for the Treatment of Female Pattern Hair Loss (Androgenetic Alopecia)

Rationale:

n/a

Purpose:

This is a six month clinical trial to evaluate the effectiveness and safety in women with Female Pattern Hair Loss (FPHL), comparing a 5% minoxidil topical foam (MTF) formulation applied once a day versus a topical foam vehicle (placebo) formulation applied once a day.

Study Status: Completed

Recruiting:
n/a

Condition Intervention Phase
Androgenetic Alopecia Drug: 5% Minoxidil Topical Foam
Drug: Vehicle Topical Foam
Phase 3

Verified by Johnson & Johnson Healthcare Products Division of McNEIL-PPC, Inc. August, 2012

Sponsored by: Johnson & Johnson Healthcare Products Division of McNEIL-PPC, Inc.
Information provided by: Johnson & Johnson Consumer and Personal Products Worldwide
ClinicalTrials.gov identifier: NCT01226459

Study Type: Interventional

Study Design: Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment

Cleveland Clinic
Cleveland, Ohio 44195
United States

Rita A Wanser., Study Director

This information is abridged to display results relevant only to Cleveland Clinic. To see complete record visit ClinicalTrials.gov
  Information obtained from ClinicalTrials.gov on
Link to the current ClinicalTrials.gov record.

Cleveland Clinic Mobile Site